US Treasury Secretary Scott Bessent on Wednesday touted US "levers" that he said could give the Trump administration an upper hand toward striking a broad trade deal with China. The US and China are ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback